Cytotoxic drugs activate KSHV lytic cycle in latently infected PEL cells by inducing a moderate ROS increase controlled by HSF1, NRF2 and p62/SQSTM1

Marisa Granato, Maria Saveria Gilardini Montani, Camilla Angiolillo, Gabriella D’orazi, Alberto Faggioni, Mara Cirone

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Cytotoxic drugs activate KSHV lytic cycle in latently infected PEL cells by inducing a moderate ROS increase controlled by HSF1, NRF2 and p62/SQSTM1'. Together they form a unique fingerprint.

Medicine & Life Sciences